Discuss treatment and driving safety
Very low certaintyADHD evidence
Raise driving at your treatment review: attention problems and possible side effects.
Start with the time you have
1 minute
Write down one driving moment that worried you, to take to your clinician.
5 minutes
Write down attention problems or side effects that could affect your driving.
15 minutes
Write a question about driving for your treatment review, and find the official local reporting guidance.
A plan
Include driving in the clinical review
- Describe driving-related difficulties and treatment effects.
- Ask the clinician about fitness to drive in your situation.
- Follow the agreed safety plan and local licensing requirements.
How sure the science is
Very low certainty, ADHD evidence
- We barely know.
- Small or short trials, and people knew what they were getting.
- The true effect could be much smaller, or zero.
- Measured in people with ADHD.
- 3 trials
- 154 people
- adults
- clinician rated
- about 12 weeks
- measured on driving
NICE NG87 1.4.3 recommends discussing driving; EBI driving trials very low certainty; registry associations non-randomised.
The number, drawn
Ask your clinician if you are unsure whether driving on treatment is safe
Why it matters
- ADHD is associated with higher transport risk, and a large registry study linked medication treatment with fewer transport accidents (adjusted rate ratio 0.88), though that does not prove cause.
- In EBI, small adult methylphenidate trials gave an uncertain driving result, SMD 0.53 with a confidence interval from -0.073 to 1.133 and very low certainty, over about 12 weeks or to trial endpoint.
- NICE recommends talking about driving after diagnosis, and NHS guidance notes that dizziness, sleepiness or sight problems from medicine can make driving unsafe.
How to do it
- Tell your prescriber whether you drive, and describe any attention worries or near misses.
- Report sleepiness, dizziness, changes in vision or any other treatment effect that matters behind the wheel.
- Ask how your symptoms and treatment affect your fitness to drive, in your circumstances.
- Check the local licensing and reporting rules with an official source.
- Do not drive if symptoms or side effects make it unsafe.
- Medication does not guarantee safe driving, so get individual clinical advice and follow local licensing rules.
Putting it into practice
In real life
- Mention a near miss at your review rather than discussing concentration only in the office.
- Ask whether dizziness or sleepiness could affect how safely you drive.
Watch out for
- Common mistakeA registry link cannot certify that you personally are safe to drive. Ask for an assessment of you.
- Common mistakeIf you only look for symptom benefit, you can miss medicine effects that make driving worse. Report both.
Trusted guides
How we rated it
- Evidence grade
- A Moderate or high certainty evidence in people with ADHD, or an explicit ADHD guideline recommendation.
- The number
- Ask your clinician if you are unsure whether driving on treatment is safe (NHS, 2025)
- Benefit
- 55/100 An editorial priority for the general list, weighted by certainty. It does not predict what will happen for you.
- Effort
- Quick win
Sources
- Tier 1 guidelineCommon questions about methylphenidate for adultsNHS, 2025
- Tier 1 guidelineEBI-ADHD: companion data to Gosling et al., BMJ 2025, commit 86eff22a9ffbBMJ / Gosling et al., 2025
- Tier 1 guidelineBenefits and harms of ADHD interventions: umbrella review and platform for shared decision makingBMJ, 2025
- Tier 2 studyADHD drug treatment and risk of suicidal behaviours, substance misuse, accidental injuries, transport accidents, and criminality: emulation of target trialsBMJ, 2025
- Tier 1 guidelineAttention deficit hyperactivity disorder: diagnosis and management (NG87), recommendationsNICE, 2019
- General information about ADHD, not a diagnosis or an individual treatment plan.
- Tailoring changes the order of suggestions; it does not assess you.
- Medication decisions belong with you and a qualified clinician.